IMCRImmunocore Holdings plc

Nasdaq immunocore.com


$ 46.28 $ 0.25 (0.54 %)    

Tuesday, 28-May-2024 15:59:30 EDT
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 46.3
$ 46.10
$ 0.00 x 0
$ 0.00 x 0
$ 45.19 - $ 46.61
$ 41.01 - $ 76.98
1,005,798
na
2.31B
$ 0.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 mizuho-maintains-buy-on-immunocore-hldgs-lowers-price-target-to-88

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $90 to...

 canaccord-genuity-maintains-hold-on-immunocore-hldgs-raises-price-target-to-67

Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from...

 hc-wainwright--co-maintains-buy-on-immunocore-hldgs-raises-price-target-to-100

HC Wainwright & Co. analyst Patrick Trucchio maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price ta...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 leerink-partners-initiates-coverage-on-immunocore-hldgs-with-outperform-rating-announces-price-target-of-74

Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Outperform rating and an...

 guggenheim-reiterates-buy-on-immunocore-hldgs-maintains-92-price-target

Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 immunocore-says-selling-shareholders-may-offer--resell-up-to-12m-ads-pursuant-to-prospectus-supplement

- SEC Filing  On April 5, 2024, Immunocore Holdings plc (the "Company") filed a prospectus supplement (the "Prospec...

 jp-morgan-maintains-overweight-on-immunocore-hldgs-raises-price-target-to-70

JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $6...

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-90-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 pric...

 mizuho-maintains-buy-on-immunocore-hldgs-raises-price-target-to-90

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $86 to...

 oppenheimer-reiterates-outperform-on-immunocore-hldgs-raises-price-target-to-87

Oppenheimer analyst Justin Kim reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Outperform and raises the price target from ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION